Cunningham Daniel J, Blatter Michael, Adams Samuel B, Gage Mark J
Duke University Department of Orthopaedic Surgery, 311 Trent Drive, Durham, NC 27710, United States.
Duke University Department of Orthopaedic Surgery, 311 Trent Drive, Durham, NC 27710, United States.
Injury. 2022 Feb;53(2):445-452. doi: 10.1016/j.injury.2021.11.039. Epub 2021 Nov 17.
The impact of time and state regulation on opioid prescribing in orthopedic trauma is not well known. The purpose of this study is to evaluate the impact of time and state-level opioid legislation on 90-day perioperative opioid prescribing in ankle fracture surgery from 2010 to 2019.
This is a retrospective, cohort study using a national insurance database including commercial insurance, Medicare, Medicaid, and cash pay patients to evaluate 30-day pre-operative to 90-day post-operative opioid prescription filling in 40,286 patients ages 18 and older undergoing Current Procedural Terminology codes 27,766, 27,769, 27,792, 27,814, 27,822, and/or 27,823 between 2010 and 2019 in all 50 United States. The primary study outcome was initial and cumulative perioperative opioid prescription filling and rates of filling and refills over the study timeframe.
Mean first prescription volume has not changed dramatically from 2010 (37 oxycodone 5 mg pills) to 2019 (33.3 oxycodone 5 mg pills). However, cumulative prescriptions within the 30PRE-90POST timeframe have decreased considerably from 2010 (128.5 oxycodone 5 mg pills) to 2019 (70.4 oxycodone 5 mg pills), and cumulative prescription filling in years 2018 and 2019 was significantly less than in 2010. Legislation targeting duration or duration and volume had the largest impacts on initial and cumulative opioid prescribing.
In ankle fracture surgery, states with opioid prescribing legislation had larger reductions in perioperative opioid prescribing compared to states without opioid legislation. Legislation targeting duration or duration and volume had the largest impacts on opioid prescribing.
Level III, Retrospective prognostic cohort study.
时间和州法规对骨科创伤患者阿片类药物处方的影响尚不清楚。本研究的目的是评估2010年至2019年期间时间和州级阿片类药物立法对踝关节骨折手术围手术期90天阿片类药物处方的影响。
这是一项回顾性队列研究,使用国家保险数据库,包括商业保险、医疗保险、医疗补助和现金支付患者,以评估2010年至2019年期间在美国所有50个州接受现行程序编码27766、27769、27792、27814、27822和/或27823的40286名18岁及以上患者术前30天至术后90天的阿片类药物处方配药情况。主要研究结果是围手术期阿片类药物的初始和累积处方配药情况,以及研究时间段内的配药率和再配药率。
从2010年(37片5毫克羟考酮)到2019年(33.3片5毫克羟考酮),平均首次处方量没有显著变化。然而,2010年(128.5片5毫克羟考酮)到2019年(70.4片5毫克羟考酮),30术前-90术后时间段内的累积处方量显著下降,2018年和2019年的累积处方配药量明显少于2010年。针对用药时长或用药时长和用量的法规对阿片类药物的初始和累积处方影响最大。
在踝关节骨折手术中,与没有阿片类药物立法的州相比,有阿片类药物处方立法的州围手术期阿片类药物处方的减少幅度更大。针对用药时长或用药时长和用量的法规对阿片类药物处方影响最大。
三级,回顾性预后队列研究。